Search Results - Poser, Philip Lennart

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational study

    Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational study by Karl, Anna-Sophia, Klimas, Rafael, Katsimpoura, Melina, Sgodzai, Melissa, Theile-Ochel, Simon, Poser, Philip Lennart, Gisevius, Barbara, Faissner, Simon, Salmen, Anke, Nastos, Ilias, Gold, Ralf, Motte, Jeremias

    Published in Journal of neurology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy

    Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy by Poser, Philip Lennart, Sajid, Gulchan Shazadi, Beyer, Léon, Hieke, Alina, Schumacher, Aurelian, Horstkemper, Lea, Karl, Anna‐Sophia, Grüter, Thomas, Sgodzai, Melissa, Pitarokoili, Kalliopi, Gerwert, Klaus, Gold, Ralf, Fisse, Anna Lena, Gisevius, Barbara, Motte, Jeremias

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Over one year of B‑cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study

    Over one year of B‑cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study by Klimas, Rafael, Karl, Anna-Sophia, Poser, Philip Lennart, Sgodzai, Melissa, Theile-Ochel, Simon, Gisevius, Barbara, Faissner, Simon, Nastos, Ilias, Gold, Ralf, Motte, Jeremias

    Published in Nervenarzt
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Über ein Jahr B-Zell-gerichtete Therapie mit Ofatumumab s.c.: erste Ergebnisse einer prospektiven, patientenzentrierten Real-world-Beobachtungsstudie

    Über ein Jahr B-Zell-gerichtete Therapie mit Ofatumumab s.c.: erste Ergebnisse einer prospektiven, patientenzentrierten Real-world-Beobachtungsstudie by Klimas, Rafael, Karl, Anna-Sophia, Poser, Philip Lennart, Sgodzai, Melissa, Theile-Ochel, Simon, Gisevius, Barbara, Faissner, Simon, Nastos, Ilias, Gold, Ralf, Motte, Jeremias

    Published in Nervenarzt
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: